Anthracyclines |
|
|
Doxorubicin |
Breast, sarcoma, lung, bladder, gastric, prostate, leukemia, lymphoma, others |
Heart failure, cardiomyopathy, arrhythmia |
Daunorubicin |
|
|
Epirubicin |
|
|
Idarubicin |
|
|
Mitoxantrone |
|
|
Alkylating agents |
|
|
Cisplatin |
Lung, bladder, testicular, breast, esophageal, head and neck |
Venous and arterial thromboembolism, hypertension |
Melphalan |
Multiple myeloma, ovarian, neuroblastoma |
Arrhythmia |
Antimetabolites |
|
|
Capecitabine |
Breast, colon, gastric, pancreatic |
Arterial (coronary) vasospasm, (myocardial) ischemia, Takotsubo |
Fluorouracil |
|
|
Monoclonal antibodies |
|
|
Bevacizumab |
Colorectal, cervical, glioblastoma, ovarian, renal, endometrial, sarcoma, breast |
Hypertension, arterial and venous thromboembolism, bleeding |
Rituximab |
Lymphoma, leukemia |
Hypotension (infusion reaction) |
Ofatumumab |
|
Hypertension |
Alemtuzumab |
|
|
Pertuzumab |
Breast, gastric, esophageal |
Heart failure, cardiomyopathy |
Trastuzumab |
|
|
Small-molecule tyrosine kinase inhibitors |
|
|
Axitinib |
Renal |
Hypertension |
Cabozantinib |
Thyroid, renal |
Hypertension, arterial and venous thromboembolism |
Cetuximab |
Lung, pancreatic, colorectal |
Arterial and venous thromboembolism |
Crizotinib |
Lung |
Bradyarrhythmia, QT prolongation |
Dabrafenib |
Melanoma |
QT prolongation |
Dasatinib |
Leukemia, gastrointestinal stromal tumor |
QT prolongation, pleural effusion, pulmonary hypertension |
Erlotinib |
Lung, pancreatic, colorectal |
Arterial and venous thromboembolism |
Ibrutinib |
Lymphoma |
Atrial fibrillation, hypertension, bleeding |
Imatinib |
Leukemia, gastrointestinal stromal tumor, myelodysplastic syndrome, melanoma, mastocytosis, sarcoma |
Edema |
Osimertinib |
Lung |
Atrial fibrillation, heart failure, cardiomyopathy. QT prolongation |
Pazopanib |
Renal, sarcoma, thyroid |
Hypertension, bradyarrhythmia, heart failure, cardiomyopathy |
Ponatinib |
Leukemia |
Heart failure, cardiomyopathy, hypertension, ischemia, arterial and venous thromboembolism |
Ramucirumab |
Colorectal, gastric, lung |
Hypertension |
Regorafenib |
Colorectal, gastrointestinal stromal tumor |
Hypertension |
Sorafenib |
Hepatocellular, renal, thyroid |
Hypertension, heart failure, cardiomyopathy, ischemia |
Sunitinib |
Renal, thyroid, sarcoma, gastrointestinal stromal tumor, pancreatic neuroendo-crine tumor |
Hypertension, heart failure, cardiomyopathy, arterial and venous thromboembolism |
Trametinib |
Melanoma |
Heart failure, cardiomyopathy, bradyarrhythmia, QT prolongation, arterial and venous thromboembolism, hypertension |
Vandetanib |
Thyroid |
Hypertension, QT prolongation |
Vemurafenib |
Melanoma |
Hypertension, QT prolongation |
Ziv-aflibercept |
Colorectal |
Hypertension |
Immune checkpoint inhibitors |
Melanoma, lung, kidney, bladder, head and neck, lymphoma |
Myocarditis, arrhythmia/sudden cardiac death, cardiomyopathy, vasculitis, pericarditis |
PD-1 inhibitors
Cemiplimab
Nivolumab
Pembrolizumab
|
|
|
PD-L1 inhibitors
Atezolizumab
Avelumab
Durvalumab
|
|
|
CTLA-4 inhibitor
|
|
|
Proteasome inhibitors |
|
|
Bortezomib |
Multiple myeloma, mantle cell lymphoma |
Hypertension |
Carfilzomib |
Multiple myeloma |
Hypertension, heart failure, cardiomyopathy, arterial and venous thromboembolism, acute coronary syndrome |
mTOR inhibitors |
|
|
Everolimus |
Breast, pancreas |
Hypertension |
Temsirolimus |
Renal |
Hypertension |
Immunomodulatory drugs |
Multiple myeloma |
Venous thromboembolism |
Lenalidomide |
|
|
Pomalidomide |
|
|
Thalidomide |
|
|
Histone deacetylase inhibitors |
Lymphoma |
QT prolongation |
Belinostat |
|
|
Vorinostat |
|
|
Endocrine therapy |
|
|
Selective estrogen receptor modulators
|
Breast |
Venous thromboembolism, QT prolongation |
Aromatase inhibitors
Anastrozole
Letrozole
Exemestane
|
Breast |
Venous thromboembolism, hypertension, hyperlipidemia |
Antiandrogens
Flutamide
Bicalutamide
Nilutamide
|
Prostate |
Hypertension, hyperlipidemia, atherosclerosis |
CYP17 inhibitor
|
Prostate |
Hypertension, myocardial infarction |
Chimeric antigen receptor T-cell therapy |
B-cell acute lymphoblastic leukemia (refractory or relapse), large B-cell lymphoma (refractory or relapse) |
Tachycardia, arrhythmia, hypotension, hypertension, heart failure, cytokine release syndrome |
Axicabtagene ciloleucel |
|
|
Tisagenlecleucel |
|
|
Miscellaneous |
|
|
Ribociclib |
Breast |
QT prolongation |
Arsenic trioxide |
Leukemia |
QT prolongation |
Tretinoin |
Leukemia |
Heart failure, cardiomyopathy |